Privacy Risks in Prenatal Aneuploidy and Carrier Screening What Obstetricians and Their Patients Need to Know

Modern prenatal genetic screening techniques such as cell-free fetal DNA and expanded carrier screening genotype substantial amounts of maternal and fetoplacental DNA. Although DNA can be deidentified by stripping protected health information from genetic data, anonymized DNA can be reidentified using genetic databases, raising long-term genetic privacy concerns for both mother and fetus. In this commentary, we explore the evolution of prenatal genetic screening and how modern screening techniques may pose unanticipated privacy risks. We highlight knowledge gaps and outline steps to improve patient awareness of and control over their genetic privacy, including specific recommendations for laboratories and prenatal care practitioners who offer screening. We also encourage our colleagues who provide prenatal care to be well informed about the privacy implications of the genetic tests we order and to be vocal advocates for our patients' genetic privacy, both with the laboratories that perform these tests and in the public sphere.

Automated summary

Modern prenatal genetic screening techniques, such as cell-free fetal DNA and expanded carrier screening, analyze substantial amounts of maternal and fetoplacental DNA. While anonymized DNA can be reidentified using genetic databases, raising long-term genetic privacy concerns, steps should be taken to improve patient awareness and control over their genetic privacy. It is important for prenatal care practitioners to be well-informed about the privacy implications of genetic tests and advocate for patients' genetic privacy.